The patients' well-being during antihypertensive treatment markedly influences their compliance. Therefore, in the last several years the effect of antihypertensive medications on the quality of life has been examined all over the world. The terminological and methodical problems at the field of quality of life resulted in difficulties regarding the comparison of the results of different working groups. This review is focused on the results of randomised, double-blind studies. We found that ACE inhibitors, calcium channel blockers and selective beta blockers have the most beneficial effect on the quality of life.
|Number of pages||3|
|Publication status||Published - Nov 7 1993|
ASJC Scopus subject areas